News
GSK plc (NYSE:GSK) is one of the best growth stocks under $50 to buy now. In a report released on September 4, David Evans ...
A little less than a year after targeting Moderna in an mRNA vaccine patent lawsuit, GSK is widening the scope of its litigation by throwing its rival’s next-generation COVID-19 shot into the fold. | ...
OXFORD, England--(BUSINESS WIRE)--Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The partnership ...
GSK Canada (GlaxoSmithKline Inc.) today announced it has started shipping doses of its trivalent seasonal influenza vaccine, ...
3d
GSK's RSV Vaccine Arexvy Included in Publicly Funded Prevention Programs for Older Adults in Canada
GSK announced today that Arexvy (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) will be offered through ...
A £2m fund set up by a pharmaceutical giant after it decided to close a factory has awarded cash to a charity-run park and a community space offering help to residents. Last year, GlaxoSmithKline (GSK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback